John Adent, CEO of Neogen Corp

John Adent has built a solid career in Food and Animal Safety. He has held management responsibilities with Ralston Purina Company, developing animal feed manufacturing and sales operations in China and the Philippines.

He later served as President and CEO of Animal Health International. He also grew the company through acquisitions and joint ventures.

Early Life and Education

John Adent is a well-known CEO who has built his career inside of two companies. He has held management positions for Ralston Purina Company developing animal feed manufacturing and sales operations in China and the Philippines. He also served as a managing director for Nestle Purina PetCare Co. in Europe where he was responsible for Hungarian operations.

He joined Patterson in 2004 as President and Chief Executive Officer of Animal Health International, a small private company that was purchased by Patterson Companies in 2015. He served as the CEO of the $3.3 billion animal health division until his resignation on July 1. During his time at Patterson, Adent helped the company grow its sales and gain a spot in Fortune 500 rankings. He also led a number of strategic acquisitions and joint ventures.

Professional Career

John Adent is currently CEO of Neogen, a company that specializes in food and animal safety. He joined the company in 2017 and brings years of experience to the table.

His background includes management responsibilities for Ralston Purina Company, developing animal feed manufacturing and sales operations in China and the Philippines. He also had leadership roles in the European division, when Ralston Purina spun off that business to Agribrands.

His career also included the leadership position of president and CEO of Animal Health International, one of the largest distributors of animal health products in the world. He was named as a member of the Colorado Agriculture Hall of Fame. The Colorado Agriculture Hall of Fame recognizes true giants in the field, whose achievements have had a real and lasting impact on agriculture.

Achievements and Honors

John Adent has spent the last 13 years as the CEO of Westlake, Texas-based Animal Health International, one of the largest distributors of food and animal health products in the world. Under his leadership, the company more than quadrupled its revenues through a series of acquisitions and joint ventures.

He recently joined Lansing-based Neogen (Nasdaq: NEOG) as its chief executive officer. As the new boss, Adent will take over the reins from his predecessor James Herbert. In addition to being named the CEO of the company, he also received a hefty compensation package, including a $1 million dollar bonus and a whopping $2.1 million in total pay. The company’s other executives got off to a good start, as well. The company’s highest paid employees received an average pay of $52,368.

Personal Life

john adent is an experienced executive with extensive experience in international food and animal safety. He is currently the CEO of Neogen Corp. He previously served as the President & Chief Executive Officer of Animal Health International (AHI), a small private company that more than quadrupled revenues over a decade through a series of acquisitions and joint ventures.

On July 17th, 2017, Neogen Corporation named Adent as its new CEO replacing James Herbert, the company’s founder and former CEO. Herbert will remain as executive chairman and will work closely with Adent in the transition of responsibilities.

Net Worth

John Adent, President and Chief Executive Officer of Neogen Corp. (NEOG), is worth at least $3.72 million as of 28 September 2022. He owns 80,103 shares of the company’s stock and has sold a total of 81,539 units in the past 4 years at an average price of $0.03. He filed a Form 4 with the Securities and Exchange Commission (SEC) on 28 September 2022 to disclose his recent trading activities. The SEC requires insiders like John Adent to report their buying and selling activity in order to prevent insider trading. The SEC also provides information about their buying and selling activity to investors so that they can track insider trading against the company’s share prices over time.